These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20503828)

  • 1. Drug eluting stents vs. bare metal stents: "lessons learnt from the past decade".
    Sharma RK; Reddy H; Voelker D; Sharma RK; King S; Singh VN
    Indian Heart J; 2009; 61(3):246-8. PubMed ID: 20503828
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized study on provisional stenting with sirolimus-eluting stent vs. bare metal stent for the treatment of true coronary bifurcations: the PROSUMER (PROvisional with sirolimus-eluting vs. bare metal stents in truE bifuRcations) study.
    Tanzilli G; Pelliccia F; Pasceri V; Speciale G; Greco C; Arrivi A; Viceconte N; Mangieri E; Gaudio C
    Int J Cardiol; 2011 Jan; 146(2):240-1. PubMed ID: 21093942
    [No Abstract]   [Full Text] [Related]  

  • 3. Three years since the FDA advisory panel on drug-eluting stents: what have we learned about off-label use and stent thrombosis?
    Naidu SS
    J Invasive Cardiol; 2010 Jan; 22(1):20-1. PubMed ID: 20048394
    [No Abstract]   [Full Text] [Related]  

  • 4. Vascular responses to percutaneous coronary intervention with bare-metal stents and drug-eluting stents: a perspective based on insights from pathological and clinical studies.
    Buja LM
    J Am Coll Cardiol; 2011 Mar; 57(11):1323-6. PubMed ID: 21376501
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on drug-eluting stents.
    Sims JM
    Dimens Crit Care Nurs; 2007; 26(6):237-40. PubMed ID: 18090139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.
    Garg P; Mauri L
    Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug-eluting stents in multivessel coronary artery disease: Was one of the important fortresses of surgery conquered?].
    Okmen AS; Okmen E
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):325-30. PubMed ID: 19666436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: bare metal stents versus drug-eluting stents for saphenous vein grafts-an interventionalist's dilemma!
    Satpathy R
    J Interv Cardiol; 2011 Apr; 24(2):181-3. PubMed ID: 21457327
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
    Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries).
    Cheng JM; Onuma Y; Piazza N; Nuis RJ; Van Domburg RT; Serruys PW;
    Am J Cardiol; 2010 Nov; 106(10):1376-81. PubMed ID: 21059424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes after coronary bare-metal-stent and drug-eluting-stent implantations: a 'real-world' comparison among patients with diabetes with diffuse small vessel coronary artery disease.
    Koh AS; Chia S; Choi LM; Sim LL; Chua TS; Koh TH; Tan JW
    Coron Artery Dis; 2011 Mar; 22(1):96-9. PubMed ID: 21164343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcome and prognosis after treatment of the first generation drug-eluting stent thrombosis.
    Moon JY; Jeong MH; Kim IS; Jeong HC; Sim DS; Hong YJ; Kim JH; Ahn Y; Kang JC
    Int J Cardiol; 2010 Dec; 145(3):564-6. PubMed ID: 20557962
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of metal allergy in patients with very late drug-eluting stent thrombosis: a pilot study.
    Hansen PR; Ahlehoff O; Gislason GH; Galløe AM; Menné T; Thyssen JP
    Int J Cardiol; 2010 Dec; 145(3):629-30. PubMed ID: 20965590
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Stenestrand U; James SK; Lindbäck J; Fröbert O; Carlsson J; Scherstén F; Nilsson T; Lagerqvist B;
    Eur Heart J; 2010 Jan; 31(2):177-86. PubMed ID: 19903684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late outcomes of drug eluting and bare metal stents in saphenous vein graft percutaneous coronary intervention.
    Nair S; Fath-Ordoubadi F; Clarke B; El-Omar M; Foley J; Fraser DG; Mahadevan VS; Neyses L; Khattar RS; Mamas MA
    EuroIntervention; 2011 Mar; 6(8):985-91. PubMed ID: 21330247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year clinical outcome after treatment of bare-metal stent in-stent restenosis with the paclitaxel-eluting stent in an unselected cohort.
    Beijk MA; Claessen BE; Koch KT; Henriques JP; Baan J; Vis MM; Meesterman M; Tijssen JG; Piek JJ; de Winter RJ
    Int J Cardiol; 2010 Dec; 145(3):608-9. PubMed ID: 20850881
    [No Abstract]   [Full Text] [Related]  

  • 20. A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trial.
    Cannon LA; Kereiakes DJ; Mann T; Popma JJ; Mooney MR; Mishkel GJ; Lee TC; Wilson BH; Stuckey TD; Orlow S; McGarry T; Ring ME; Kellett MA; Underwood P; Dawkins KD
    EuroIntervention; 2011 Mar; 6(8):920-7, 1-2. PubMed ID: 21330238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.